semaglutide and immune system – the Surprising New Anti-Fibrosis Drug Microdosing Semaglutide: Weight Loss Plus
Description
With the Boards of Appeal revoking several Novo Nordisk patents relating to the active ingredient semaglutide in recent months, this represents a success for the patent holder
Goal: implement structured 16:8 fasting while maintaining nutritional adequacy
The Journal of Nutrition
In a phase 2 randomised controlled trial published in the New England Journal of Medicine (Jastreboff et al., 2023), participants receiving the highest doses of retatrutide achieved a mean weight reduction of approximately 1724% of body weight over 48 weeks, depending on dose
10.1152/ajpendo.1997.273.5.E981 82
